Epigral Ltd. | Mid-cap | Basic Materials
₹1,738.10
0.39%
| Epigral Stock Comparison:

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 25.5B
Gross Profit 12.0B 46.92%
Operating Income 5.8B 22.67%
Net Income 3.6B 14.03%

Balance Sheet Metrics

Total Assets 31.5B
Total Liabilities 12.5B
Shareholders Equity 19.0B
Debt to Equity 0.66

Cash Flow Metrics

Operating Cash Flow 4.2B
Free Cash Flow 2.5B

Revenue & Profitability Trend

Epigral Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 25.5B 18.9B 21.7B 15.5B 8.3B
Cost of Goods Sold 13.5B 11.2B 11.7B 8.0B 4.1B
Gross Profit 12.0B 7.8B 10.0B 7.5B 4.1B
Operating Expenses 3.7B 2.2B 2.3B 1.5B 907.0M
Operating Income 5.8B 3.6B 5.8B 4.2B 1.9B
Pre-tax Income 5.4B 2.9B 5.2B 3.8B 1.6B
Income Tax 1.8B 948.8M 1.7B 1.3B 600.2M
Net Income 3.6B 2.0B 3.5B 2.5B 1.0B
EPS (Diluted) - ₹47.14 ₹85.03 ₹60.84 ₹17.26

Income Statement Trend

Epigral Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 7.8B 5.0B 4.2B 4.5B 1.8B
Non-Current Assets 23.8B 22.9B 20.1B 16.8B 12.7B
Total Assets 31.5B 27.9B 24.3B 21.2B 14.5B
Liabilities
Current Liabilities 4.9B 7.8B 6.5B 5.3B 3.9B
Non-Current Liabilities 7.6B 7.6B 7.2B 8.7B 3.8B
Total Liabilities 12.5B 15.4B 13.6B 14.0B 7.6B
Equity
Total Shareholders Equity 19.0B 12.5B 10.7B 7.3B 6.8B

Balance Sheet Composition

Epigral Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 5.4B 2.9B 5.2B 3.8B 1.6B
Operating Cash Flow 4.2B 2.7B 6.1B 2.4B 1.6B
Investing Activities
Capital Expenditures -1.9B -4.0B -4.2B -4.6B -2.0B
Investing Cash Flow -2.6B -4.0B -4.4B -4.5B -2.0B
Financing Activities
Dividends Paid -418.6M -251.2M -242.2M - -
Financing Cash Flow -2.6B 658.6M -1.4B 2.4B 88.1M
Free Cash Flow 2.5B -7.9M 2.1B -1.7B 324.2M

Cash Flow Trend

Epigral Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 20.49
Forward P/E 18.00
Price to Book 3.93
Price to Sales 2.94
PEG Ratio 18.00

Profitability Ratios

Profit Margin 14.03%
Operating Margin 22.22%
Return on Equity 22.65%
Return on Assets 12.15%

Financial Health

Current Ratio 1.57
Debt to Equity 31.11
Beta -0.14

Per Share Data

EPS (TTM) ₹84.67
Book Value per Share ₹441.46
Revenue per Share ₹603.74

Financial data is updated regularly. All figures are in the company's reporting currency.